Giving Patients' Preferences a Voice in Medical Treatment Life Cycle: The PREFER Public-Private Project

Affiliations

¹ Section of Health Technology Assessment and Erasmus Choice Modelling Centre, Institute of Health Policy and Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands. debekker-grob@bmg.eur.nl.
² Section of Medical Decision Making and Erasmus Choice Modelling Centre, Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands. debekker-grob@bmg.eur.nl.
³ Novartis Pharma AG, Basel, Switzerland.
⁴ Janssen R&D LLC, Titusville, NJ, USA.
⁵ Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
⁶ Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
⁷ European Cancer Patient Coalition, Brussels, Belgium.
⁸ Belgian Health Care Knowledge Centre, Brussels, Belgium.
⁹ Diagnóza Leukemie, Prague, Czech Republic.
¹⁰ Federal Institute for Drugs and Medical Devices, Bonn, Germany.
¹¹ Department of Public Health and Caring Sciences, Centre for Research Ethics and Bioethics, Uppsala University, Uppsala, Sweden.

Editorial

Esther W de Bekker-Grob et al. Patient. 2017 Jun.

. 2017 Jun;10(3):263-266.

doi: 10.1007/s40271-017-0222-3.

¹ Section of Health Technology Assessment and Erasmus Choice Modelling Centre, Institute of Health Policy and Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands. debekker-grob@bmg.eur.nl.
² Section of Medical Decision Making and Erasmus Choice Modelling Centre, Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands. debekker-grob@bmg.eur.nl.
³ Novartis Pharma AG, Basel, Switzerland.
⁴ Janssen R&D LLC, Titusville, NJ, USA.
⁵ Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
⁶ Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
⁷ European Cancer Patient Coalition, Brussels, Belgium.
⁸ Belgian Health Care Knowledge Centre, Brussels, Belgium.
⁹ Diagnóza Leukemie, Prague, Czech Republic.
¹⁰ Federal Institute for Drugs and Medical Devices, Bonn, Germany.
¹¹ Department of Public Health and Caring Sciences, Centre for Research Ethics and Bioethics, Uppsala University, Uppsala, Sweden.

No abstract available

References